Biocept, Inc. to Present at the Molecular Medicine Tri-Conference on Circulating Tumor Cell (CTC) Technologies

Published: Feb 21, 2012

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that two of its senior scientists, Farideh Bischoff, Ph.D., Vice President of Translational Research, and Lyle Arnold, Ph.D., Senior Vice President, R&D and Chief Scientific Officer, will be making presentations at the 19th Annual Molecular Medicine Tri-Con being held in San Francisco February 19-23.

Back to news